BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 12243825)

  • 1. Comparison of granulocyte-macrophage colony-stimulating factor and sucralfate mouthwashes in the prevention of radiation-induced mucositis: a double-blind prospective randomized phase III study.
    Saarilahti K; Kajanti M; Joensuu T; Kouri M; Joensuu H
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):479-85. PubMed ID: 12243825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: a prospective randomized study.
    Makkonen TA; Minn H; Jekunen A; Vilja P; Tuominen J; Joensuu H
    Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):525-34. PubMed ID: 10701730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
    Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation-induced mucositis: a randomized clinical trial of micronized sucralfate versus salt & soda mouthwashes.
    Dodd MJ; Miaskowski C; Greenspan D; MacPhail L; Shih AS; Shiba G; Facione N; Paul SM
    Cancer Invest; 2003; 21(1):21-33. PubMed ID: 12643006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sucralfate mouth washing in the prevention of radiation-induced mucositis: a placebo-controlled double-blind randomized study.
    Makkonen TA; Boström P; Vilja P; Joensuu H
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):177-82. PubMed ID: 8083112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte macrophage-colony-stimulating factor mouthwashes heal oral ulcers during head and neck radiotherapy.
    Rovirosa A; Ferre J; Biete A
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):747-54. PubMed ID: 9652834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma.
    Kannan V; Bapsy PP; Anantha N; Doval DC; Vaithianathan H; Banumathy G; Reddy KB; Kumaraswamy SV; Shenoy AM
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1005-10. PubMed ID: 9169806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sucralfate in the prevention of radiation-induced oral mucositis.
    Cengiz M; Ozyar E; Oztürk D; Akyol F; Atahan IL; Hayran M
    J Clin Gastroenterol; 1999 Jan; 28(1):40-3. PubMed ID: 9916664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of the effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during X-radiation therapy: a preliminary report.
    Nicolatou O; Sotiropoulou-Lontou A; Skarlatos J; Kyprianou K; Kolitsi G; Dardoufas K
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):551-6. PubMed ID: 9806514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment on: Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: a prospective randomized study.
    Kilic D; Akcali Z
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1373-4. PubMed ID: 11503611
    [No Abstract]   [Full Text] [Related]  

  • 11. Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis.
    Sprinzl GM; Galvan O; de Vries A; Ulmer H; Gunkel AR; Lukas P; Thumfart WF
    Eur J Cancer; 2001 Nov; 37(16):2003-9. PubMed ID: 11597377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
    Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
    Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The optimal use of granulocyte macrophage colony stimulating factor in radiation induced mucositis in head and neck squamous cell carcinoma.
    Patni N; Patni S; Bapna A
    J Cancer Res Ther; 2005; 1(3):136-41. PubMed ID: 17998644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trial.
    Hejna M; Köstler WJ; Raderer M; Steger GG; Brodowicz T; Scheithauer W; Wiltschke C; Zielinski CC
    Eur J Cancer; 2001 Nov; 37(16):1994-2002. PubMed ID: 11597376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash.
    Nicolatou-Galitis O; Dardoufas K; Markoulatos P; Sotiropoulou-Lontou A; Kyprianou K; Kolitsi G; Pissakas G; Skarleas C; Kouloulias V; Papanicolaou V; Legakis NJ; Velegraki A
    J Oral Pathol Med; 2001 Sep; 30(8):471-80. PubMed ID: 11545238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and histopathological evaluation of sucralfate in prevention of oral mucositis induced by radiation therapy in patients with head and neck malignancies.
    Etiz D; Erkal HS; Serin M; Küçük B; Hepari A; Elhan AH; Tulunay O; Cakmak A
    Oral Oncol; 2000 Jan; 36(1):116-20. PubMed ID: 10889930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy.
    Chi KH; Chen CH; Chan WK; Chow KC; Chen SY; Yen SH; Chao JY; Chang CY; Chen KY
    J Clin Oncol; 1995 Oct; 13(10):2620-8. PubMed ID: 7595716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sucralfate for radiation mucositis: results of a double-blind randomized trial.
    Meredith R; Salter M; Kim R; Spencer S; Weppelmann B; Rodu B; Smith J; Lee J
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):275-9. PubMed ID: 9069297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study.
    Cartee L; Petros WP; Rosner GL; Gilbert C; Moore S; Affronti ML; Hoke JA; Hussein AM; Ross M; Rubin P
    Cytokine; 1995 Jul; 7(5):471-7. PubMed ID: 7578986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of recombinant human granulocyte colony-stimulating factor mouthwash on radiotherapy-induced oral mucositis in locally advanced nasopharyngeal carcinoma patients.
    Liang G; Du W; Ke Q; Huang B; Yang J
    Adv Clin Exp Med; 2017; 26(3):409-413. PubMed ID: 28791814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.